Skip to main content
Clinical Trials/NCT01057888
NCT01057888
Completed
N/A

Randomized Controlled Trial of an Automated, Managed Care-based Reminder/Recall System on Improving Rates of Immunization and Preventive Care Visits for Publically Insured Adolescents

University of California, Los Angeles0 sites10,599 target enrollmentDecember 2009

Overview

Phase
N/A
Intervention
Not specified
Conditions
Immunization Status
Sponsor
University of California, Los Angeles
Enrollment
10599
Primary Endpoint
Well Child Care Status
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

The investigators will design and implement a randomized clinical trial to test, on a community-wide level, the effectiveness of managed care based tracking/reminder/recall on improving vaccination coverage among adolescents.

The investigators propose a randomized controlled trial to evaluate the effectiveness of reminder/recall for adolescents: 10,599 adolescents within the managed care organization (MCO) will be randomized into one of three arms: 1) mailed reminders, 2) autodialer telephone messages or 3) standard of care of their practice (no messages from the intervention).

Hypothesis 1: Reminder/recall will increase the receipt of immunizations and preventive services

Hypothesis 2: Telephone (autodialer) reminders will be more effective than mailed reminders

Hypothesis 3: The impact of reminders will be greatest for the most high-risk subgroups which have low baseline immunization rates.

Hypothesis 4: Mailed reminders will be more costly (and less effective) than telephone reminders.

Registry
clinicaltrials.gov
Start Date
December 2009
End Date
December 2010
Last Updated
10 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Peter G Szilagyi MD MPH

Professor

University of Rochester

Eligibility Criteria

Inclusion Criteria

  • Member of the Monroe Plan for Medical Care (managed care organization)
  • Patient of a participating practice
  • Ages 10.75 to \<18 years of age

Exclusion Criteria

  • Member of the Monroe Plan for Medical care for less than 6 months
  • ICD-9 diagnosis of 999.4 for anaphylactic reaction to a vaccine or its components.
  • Encephalopathy within 7 days of a previous dose of a pertussis containing vaccine not attributable to another identifiable cause
  • Guillain-Barre- ICD-9 code is 357.0

Outcomes

Primary Outcomes

Well Child Care Status

Time Frame: 12 months

Received recommended well child care visit

Fully Vaccinated (Tdap, Menactra and 3 Doses of HPV (if Female))

Time Frame: 12 months

Similar Trials